Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory
Pharma
United's Tyvaso backs up case for IPF expansion with ph. 3 win
With a second phase 3 win for Tyvaso in idiopathic pulmonary fibrosis (IPF), United Therapeutics is padding the case for an expansion.
Fraiser Kansteiner
Mar 30, 2026 3:06pm
Bayer tees up Kerendia for major CKD label expansion
Mar 16, 2026 9:46am
Merck seeks Enflonsia expansion to rival Sanofi, AZ's Beyfortus
Feb 19, 2026 10:40am
Novartis jockeys for Rhapsido FDA nod in unclaimed hives subtype
Feb 18, 2026 9:49am
PTC withdraws US approval filing for Duchenne drug Translarna
Feb 13, 2026 10:05am
FDA launches PreCheck program to ease US drug plant build-outs
Feb 2, 2026 10:27am
